BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products.

This development allows for the further testing of the CB Therapeutics production process in much larger commercial bioreactors.

United Spinal Association and Wheeling Forward are co-hosting Wine on Wheels in Portland, Oregon on August 1 at the Ecotrust Rooftop Terrace to raise funds to improve the quality of life and independence of wheelchair users nationwide.

Event aligns with RUSVM’s emphasis on One Health research and education

Raymond James Ltd., the Canadian arm of North American investment dealer Raymond James Financial Inc., today announced that Rahul Sarugaser has joined its Canadian Equity Research team as Managing Director, Equity Analyst, Healthcare, Biotechnology & Cannabis.

Physicians’ Education Resource®, LLC (PER®), a worldwide leading resource for continuing medical education, has released the agenda for the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Portage Biotech Inc., (“Portage” or the “Company”) (CSE: PBT.U, OTC Markets: PTGEF) today announced it has entered in an agreement with Fast Forward Innovations Limited (AIM Market: FFWD) (“Fast Forward”) to purchase Intensity Holdings Limited (“IHL”), a wholly-owned subsidiary of fast forward.

Company provides Circle of Care $50,000 grant on behalf of local office

Healthy.io, the global leader in turning the smartphone camera into a clinical grade medical device, today released a joint study with researchers from the Johns Hopkins University School of Medicine measuring the feasibility and acceptability of Dip.io, the smartphone-based, at-home urinalysis test, among pregnant women receiving prenatal care.

ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of a major milestone with the enrollment of the 50th patient in its U.S. based VENT-AVOID clinical trial.